From an early morning treadmill run to some “detective-like” lab work,this is how a senior cancer researcher spends her day.
Authorities are considering adding warning labels to the common asthma drug montelukast due to its link with depression,nightmares and suicidal thoughts.
It has a bunch of hurdles to jump and won’t be without its detractors,but for investors it will be something of a white whale.
Imagine a world in the near future where safe,effective weight loss drugs are widespread and larger bodies have become unusual. Is this a vision to be cheered or feared?
How much of a fresh start does the Sackler family deserve – without having to declare bankruptcy themselves?
A new counterculture is seeing people push back against the industries that are harming our health.
If we can’t trust scientific studies funded by vested interests,should we ban commercial funding of research altogether?
Muscle-mass preservation is becoming a hot new area in obesity medicine.
Investment mania around a new family of drugs that purportedly offer a miracle cure for obesity has made some pharmaceutical companies into supergiants.
The past few days have been a reckoning for Pfizer,the pharma giant that gained most from the pandemic and has seen the biggest blow from its decline as demand for COVID shots and pills declined.
The Shingrix vaccine will be available for free from November 1 for all over 65s,First Nations people aged over 50 and immunocompromised people over 18.